FXR−/− mice exhibit peripheral insulin resistance, reduced glucose disposal, and decreased adipose tissue and skeletal muscle insulin signaling, and, conversely, activation of FXR by the agonist GW4064 in insulin-resistant ob/ob mice reduced hyperinsulinemia and improved glucose tolerance [42]. The gene discussed is NR1H4; the disease is hyperinsulinism.